Perrigo Company plc (PRGO) Financials
PRGO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 10.8 billion | 6.0 billion |
| 2023-09-30 | 10.8 billion | 6.0 billion |
| 2023-06-30 | 11.0 billion | 6.1 billion |
| 2023-03-31 | 11.0 billion | 6.1 billion |
PRGO Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 182.0 million | 10.6 million |
| 2023-09-30 | 92.7 million | 14.7 million |
| 2023-06-30 | 32.9 million | 18.6 million |
| 2023-03-31 | -3.8 million | 24.9 million |
PRGO Net Income
No data available :(
PRGO Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 751.3 million | - | - |
| 2023-09-30 | 598.3 million | - | 173.0 million |
| 2023-06-30 | 555.2 million | 4.1 billion | 180.3 million |
| 2023-03-31 | 553.0 million | 4.1 billion | 184.7 million |
PRGO Shares Outstanding
PRGO Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 26.7 million | 29.6 million | 128.7 million | 178.1 million |
| 2023-09-30 | 31.8 million | 29.6 million | 126.0 million | 178.0 million |
| 2023-06-30 | 20.0 million | 32.2 million | 132.6 million | 199.7 million |
| 2023-03-31 | 23.2 million | 31.1 million | 135.0 million | 196.5 million |
PRGO Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 1.2 billion | 729.6 million |
| 2023-09-30 | 1.1 billion | 712.6 million |
| 2023-06-30 | 1.2 billion | 765.1 million |
| 2023-03-31 | 1.2 billion | 767.9 million |
PRGO
List: Contenders
Price: $31.94
Dividend Yield: 0.03%
Forward Dividend Yield: 3.53%
Payout Ratio: 1380.00%
Dividend Per Share: 1.10 USD
Earnings Per Share: -0.03 USD
P/E Ratio: 394.50
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 680000
Ebitda: 274.7 millionMarket Capitalization: 4.1 billion
Average Dividend Frequency: 4
Years Paying Dividends: 22
DGR3: 7.19%
DGR5: 9.50%
DGR10: 12.02%